Ovarian cancer risk is reduced by prolonged lactation: A case-control study in southern China

American Journal of Clinical Nutrition

Volumn 97, Issue 2, 2013, Pages 354-359

  Su, Dada ^a   Pasalich, Maria ^a   Lee, Andy H ^a   Binns, Colin W ^a  

^a CURTIN UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BREAST FEEDING; CANCER RISK; CASE CONTROL STUDY; CHINA; CHINESE; CONTROLLED STUDY; DISEASE ASSOCIATION; DOSE RESPONSE; FEMALE; HUMAN; LACTATION; MAJOR CLINICAL STUDY; OVARY CANCER; PROLONGED LACTATION; QUESTIONNAIRE; RISK ASSESSMENT; RISK REDUCTION; TIME;

CASE-CONTROL STUDIES; CHINA; FEMALE; HOSPITALS, PUBLIC; HUMANS; INCIDENCE; LACTATION; LOGISTIC MODELS; MIDDLE AGED; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; QUESTIONNAIRES; RISK; TIME FACTORS;

EID: 84873366190     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.112.044719     Document Type: Article

References (57)

1. Ferlay J, Shin H, Bray F, Forman D, Mathers C, Parkin D. Cancer incidence and mortality worldwide. Lyon, France: International Agency for Research on Cancer. 2010. Available from: http://globocan.iarc.fr (cited 25 April 2012).
2. Sankaranarayanan R, Ferlay J. Worldwide burden of gynaecological cancer: the size of the problem. Best Pract Res Clin Obstet Gynaecol 2006; 20: 207-25.
3. Cho KR, Shih I. Ovarian cancer. Annu Rev Pathol 2009; 4: 287-313.
4. Lutz AM, Willmann JK, Drescher CW, Ray P, Cochran FV, Urban N, Gambhir SS. Early diagnosis of ovarian carcinoma: is a solution in sight? Radiology 2011; 259: 329-45.
5. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012; 62: 10-29.
6. Fathalla MF. Incessant ovulation - a factor in ovarian neoplasia? Lancet 1971; 2:163.
7. Cramer DW, Welch WR. Determinants of ovarian cancer risk. II. Inferences regarding pathogenesis. J Natl Cancer Inst 1983; 71: 717-21.
8. Beral V, Doll R, Hermon C, Peto R, Reeves G, Collaborative Group on Epidemiological Studies of Ovarian Cancer. Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiolog-ical studies including 23,257 women with ovarian cancer and 87,303 controls. Lancet 2008; 371: 303-14.
9. Bosetti C, Negri E, Trichopoulos D, Franceschi S, Beral V, Tzonou A, Parazzini F, Greggi S, La Vecchia C. Long-term effects of oral contraceptives on ovarian cancer risk. Int J Cancer 2002; 102: 262-5.
10. Milne RL, Osorio A, Ramon y Cajal T, Baiget M, Lasa A, Diaz-Rubio E, de la Hoya M, Caldes T, Teule A, Lazaro C, et al. Parity and the risk of breast and ovarian cancer in BRCA1 and BRCA2 mutation carriers. Breast Cancer Res Treat 2010; 119: 221-32.
11. Kurian AW, Balise RR, McGuire V, Whittemore AS. Histologic types of epithelial ovarian cancer: have they different risk factors? Gynecol Oncol 2005; 96: 520-30.
12. Siskind V, Green A, Bain C, Purdie D. Beyond ovulation: oral contraceptives and epithelial ovarian cancer. Epidemiology 2000; 11: 106-10.
13. McNeilly AS. Lactational control of reproduction. Reprod Fertil Dev 2001; 13: 583-90.
14. Jordan SJ, Cushing-Haugen KL, Wicklund KG, Doherty JA, Rossing MA. Breast-feeding and risk of epithelial ovarian cancer. Cancer Causes Control 2012; 23: 919-27.
15. Titus-Ernstoff L, Rees JR, Terry KL, Cramer DW. Breast-feeding the last born child and risk of ovarian cancer. Cancer Causes Control 2010; 21: 201-7.
16. McLaughlin JR, Risch HA, Lubinski J, Moller P, Ghadirian P, Lynch H, Karlan B, Fishman D, Rosen B, Neuhausen SL, et al. Reproductive risk factors for ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study. Lancet Oncol 2007; 8: 26-34.
17. Zhang M, Lee AH, Binns CW. Reproductive and dietary risk factors for epithelial ovarian cancer in China. Gynecol Oncol 2004; 92: 320-6.
18. Titus-Ernstoff L, Perez K, Cramer DW, Harlow BL, Baron JA, Greenberg ER. Menstrual and reproductive factors in relation to ovarian cancer risk. Br J Cancer 2001; 84: 714-21.
19. Gwinn ML, Lee NC, Rhodes PH, Layde PM, Rubin GL. Pregnancy, breast feeding, and oral contraceptives and the risk of epithelial ovarian cancer. J Clin Epidemiol 1990; 43: 559-68.
20. Jordan SJ, Siskind V, C Green A, Whiteman DC, Webb PM. Breastfeeding and risk of epithelial ovarian cancer. Cancer Causes Control 2010; 21: 109-16.
21. Huusom LD, Frederiksen K, Hogdall EVS, Glud E, Christensen L, Hogdall CK, Blaakaer J, Kjaer SK. Association of reproductive factors, oral contraceptive use and selected lifestyle factors with the risk of ovarian borderline tumors: a Danish case-control study. Cancer Causes Control 2006; 17: 821-9.
22. Mills PK, Riordan DG, Cress RD. Epithelial ovarian cancer risk by invasiveness and cell type in the Central Valley of California. Gynecol Oncol 2004; 95: 215-25.
23. Greggi S, Parazzini F, Paratore MP, Chatenoud L, Legge F, Mancuso S, La Vecchia C. Risk factors for ovarian cancer in central Italy. Gynecol Oncol 2000; 79: 50-4.
24. Risch HA, Weiss NS, Lyon JL, Daling JR, Liff JM. Events of reproductive life and the incidence of epithelial ovarian cancer. Am J Epidemiol 1983; 117: 128-39.
25. Zhang M, Xie X, Lee AH, Binns CW. Prolonged lactation reduces ovarian cancer risk in Chinese women. Eur J Cancer Prev 2004; 13: 499-502.
26. Chiaffarino F, Pelucchi C, Negri E, Parazzini F, Franceschi S, Talamini R, Montella M, Ramazzotti V, La Vecchia C. Breastfeeding and the risk of epithelial ovarian cancer in an Italian population. Gynecol Oncol 2005; 98: 304-8.
27. Hirose K, Tajima K, Hamajima N, Kuroishi T, Kuzuya K, Miura S, Tokudome S. Comparative case-referent study of risk factors among hormone-related female cancers in Japan. Jpn J Cancer Res 1999; 90: 255-61.
28. Chen Y, Wu PC, Lang JH, Ge WJ, Hartge P, Brinton LA. Risk factors for epithelial ovarian cancer in Beijing, China. Int J Epidemiol 1992; 21: 23-9.
29. Booth M, Beral V, Smith P. Risk factors for ovarian cancer: a case-control study. Br J Cancer 1989; 60: 592-8.
30. Yen ML, Yen BL, Bai C-h, Lin RS. Risk factors for ovarian cancer in Taiwan: a case-control study in a low-incidence population. Gynecol Oncol 2003; 89: 318-24.
31. Danforth KN, Tworoger SS, Hecht JL, Rosner BA, Colditz GA, Hankinson SE. Breastfeeding and risk of ovarian cancer in two prospective cohorts. Cancer Causes Control 2007; 18: 517-23.
32. Mink PJ, Folsom AR, Sellers TA, Kushi LH. Physical activity, waist-to-hip ratio, and other risk factors for ovarian cancer: a follow-up study of older women. Epidemiology 1996; 7: 38-45.
33. Kim K, Zang R, Choi SC, Ryu SY, Kim JW. Current status of gynecological cancer in China. J Gynecol Oncol 2009; 20: 72-6.
34. Heintz AP, Odicino F, Maisonneuve P, Quinn MA, Benedet JL, Creasman WT, Ngan HY, Pecorelli S, Beller U. Carcinoma of the ovary. FIGO (International Federation of Gynecology and Obstetrics) 26th annual report on the results of treatment in gynecological cancer. Int J Gynaecol Obstet 2006; 95:S161-92.
35. Goodman MT, Hankin JH, Wilkens LR, Lyu LC, McDuffie K, Liu LQ, Kolonel LN. Diet, body size, physical activity, and the risk of endo-metrial cancer. Cancer Res 1997; 57: 5077-85.
36. World Cancer Research Fund/American Institute for Cancer Research. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Washington, DC: WCR/AICR, 2007.
37. Cramer DW. The epidemiology of endometrial and ovarian cancer. Hematol Oncol Clin North Am 2012; 26: 1-12.
38. Ip S, Chung M, Raman G, Trikalinos TA, Lau J. A summary of the Agency for Healthcare Research and Quality's evidence report on breastfeeding in developed countries. Breastfeed Med 2009; 4(suppl 1): S17-30.
39. Whittemore AS. Personal characteristics relating to risk of invasive epithelial ovarian cancer in older women in the United States. Cancer 1993; 71(suppl): 558-65.
40. Riman T, Nilsson S, Persson IR. Review of epidemiological evidence for reproductive and hormonal factors in relation to the risk of epithelial ovarian malignancies. Acta Obstet Gynecol Scand 2004; 83: 783-95.
41. Siskind V, Green A, Bain C, Purdie D. Breastfeeding, menopause, and epithelial ovarian cancer. Epidemiology 1997; 8: 188-91.
42. Tung K-H, Wilkens LR, Wu AH, McDuffie K, Nomura AMY, Kolonel LN, Terada KY, Goodman MT. Effect of anovulation factors on preand postmenopausal ovarian cancer risk: revisiting the incessant ovulation hypothesis. Am J Epidemiol 2005; 161: 321-9.
43. Malkani PK, Mirchandani JJ. "Ovulation during lactation" as determined by endometrial biopsy. J Obstet Gynaecol India 1960; 11: 121-7.
44. Cronin TJ. Influence of lactation upon ovulation. Lancet 1968; 2: 422-4.
45. Chao S. The effect of lactation on ovulation and fertility. Clin Perinatol 1987; 14: 39-50.
46. Cui N, Tang G, Li M, Xie L, Yang X. An analysis of breastfeeding patterns and menses returning in Chengdu, China. J Obstet Gynaecol Res 1999; 25: 265-70.
47. McNeilly AS, Tay CC, Glasier A. Physiological mechanisms underlying lactational amenorrhea. Ann N YAcad Sci 1994; 709: 145-55.
48. McNeilly AS. Prolactin and the control of gonadotrophin secretion in the female. J Reprod Fertil 1980; 58: 537-49.
49. Hanna L, Adams M. Prevention of ovarian cancer. Best Pract Res Clin Obstet Gynaecol 2006; 20: 339-62.
50. Zheng H, Kavanagh JJ, Hu W, Liao Q, Fu S. Hormonal therapy in ovarian cancer. Int J Gynecol Cancer 2007; 17: 325-38.
51. Brodowska A, Laszczynska M, Brodowski J, Masiuk M, Starczewski A. Analysis of pituitary gonadotropin concentration in blood serum and immunolocalization and immunoexpression of follicle stimulating hormone and luteinising hormone receptors in ovaries of postmenopausal women. Histol Histopathol 2012; 27: 241-8.
52. Parrott JA, Doraiswamy V, Kim G, Mosher R, Skinner MK. Expression and actions of both the follicle stimulating hormone receptor and the luteinizing hormone receptor in normal ovarian surface epithelium and ovarian cancer. Mol Cell Endocrinol 2001; 172: 213-22.
53. Chu S, Rushdi S, Zumpe ET, Mamers P, Healy DL, Jobling T, Burger HG, Fuller PJ. FSH-regulated gene expression profiles in ovarian tumours and normal ovaries. Mol Hum Reprod 2002; 8: 426-33.
54. Choi J-H, Wong AST, Huang H-F, Leung PCK. Gonadotropins and ovarian cancer. Endocr Rev 2007; 28: 440-61.
55. Chudecka-Glaz A, Rzepka-Górska I, Kosmowska B. Gonadotropin (LH, FSH) levels in serum and cyst fluid in epithelial tumors of the ovary. Arch Gynecol Obstet 2004; 270: 151-6.
56. Cramer DW, Xu H. Epidemiologic evidence for uterine growth factors in the pathogenesis of ovarian cancer. Ann Epidemiol 1995; 5: 310-4.
57. Risch HA. Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone. J Natl Cancer Inst 1998; 90: 1774-86.